We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Wegovy (Semeglutide) Injections for Weight Loss on the NHS
Semaglutide (Wegovy) launched in the UK on 4 September and is available on the NHS as an option for weight management in line with NICE guidance, alongside a reduced-calorie diet and increased physical activity.
Patients are eligible for treatment within a specialist weight management service if they have at least one weight-related comorbidity, such as hypertension or cardiovascular disease, and either a BMI of at least 35 or a BMI of 30 to 34.9, provided they meet the criteria for referral to specialist weight management services, including that conventional treatment has been unsuccessful.
If you meet the criteria and wish to discuss with your GP please call the surgery to arrange a routine appointment.
Accessing Wegovy for weight loss: Everything you need to know
Published: Jan 29, 2024